Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2025-12-25 @ 9:33 PM
Study NCT ID:
NCT00325351
Status:
COMPLETED
Last Update Posted:
2021-04-08
First Post:
2006-05-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-08-24
Start Date Type:
ACTUAL
Primary Completion Date:
2008-07-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-03-25
Completion Date Type:
ACTUAL
First Submit Date:
2006-05-11
First Submit QC Date:
None
Study First Post Date:
2006-05-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-06
Last Update Post Date:
2021-04-08
Last Update Post Date Type:
ACTUAL